Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience
Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morph...
Gespeichert in:
Veröffentlicht in: | Annales de cardiologie et d'angeiologie 2013-11, Vol.62 (5), p.283 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | 283 |
container_title | Annales de cardiologie et d'angeiologie |
container_volume | 62 |
creator | Pansieri, M Barnay, P Larderet, E Krebs, G Aboukhoudir, F Andrieu, S Cheggour, S Faugier, J-P Metge, M Hirsch, J-L |
description | Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures.
regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin. |
doi_str_mv | 10.1016/j.ancard.2013.08.020 |
format | Article |
fullrecord | <record><control><sourceid>hal_pubme</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01333858v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_01333858v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-h904-8ef7a5419a456c7564d81d309d04899f6a2b916d31553ad98d87b009a0a3db863</originalsourceid><addsrcrecordid>eNo90FFLwzAQB_Agihtz30Akrz60Xpo2TXwbQ50w2ZC9j-uSrpEuKWk33Sfwa9sx9eng7nfH8SfklkHMgImHjxjdBoOOE2A8BhlDAhdkyHIhI84kuyRDAOARV4kckHHb2gKYEkmeM3FNBkkKAlKRDsn3u3FYU22cCQfsrHe09IEG09q2Q9fR6tiY0BnXnkaftqv8vqPbE-_X0Jm2q3qLjxT1ofe4NdSXFOnb02I5oTsfmso6Q5vgO7_xdUyXwdR2Zx2GIzVf_XFr3MbckKsS69aMf-uIrJ6fVtNZNF-8vE4n86hSkEbSlDlmKVOYZmKTZyLVkmkOSkMqlSoFJoViQnOWZRy1klrmBYBCQK4LKfiI3J_PVlivm2B3_Rdrj3Y9m8zXp14fJ-cykwfW27uzbfbFzuh__hce_wGVenWF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</creator><creatorcontrib>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</creatorcontrib><description>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA<5), in three cases intense (EVA>5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures.
regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</description><identifier>ISSN: 0003-3928</identifier><identifier>EISSN: 1768-3181</identifier><identifier>DOI: 10.1016/j.ancard.2013.08.020</identifier><identifier>PMID: 24060464</identifier><language>eng ; fre</language><publisher>France: Elsevier Masson</publisher><subject><![CDATA[Aged ; Analgesics, Non-Narcotic - administration & dosage ; Analgesics, Opioid - administration & dosage ; Catheter Ablation - adverse effects ; Catheter Ablation - methods ; Denervation - methods ; Drug Combinations ; Female ; Humans ; Hypertension - surgery ; Life Sciences ; Male ; Middle Aged ; Morphine - administration & dosage ; Nitrous Oxide - administration & dosage ; Oxygen Compounds - administration & dosage ; Pain - etiology ; Pain - prevention & control ; Pain Measurement ; Renal Artery - surgery]]></subject><ispartof>Annales de cardiologie et d'angeiologie, 2013-11, Vol.62 (5), p.283</ispartof><rights>Copyright © 2013. Published by Elsevier SAS.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-1142-770X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24060464$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01333858$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pansieri, M</creatorcontrib><creatorcontrib>Barnay, P</creatorcontrib><creatorcontrib>Larderet, E</creatorcontrib><creatorcontrib>Krebs, G</creatorcontrib><creatorcontrib>Aboukhoudir, F</creatorcontrib><creatorcontrib>Andrieu, S</creatorcontrib><creatorcontrib>Cheggour, S</creatorcontrib><creatorcontrib>Faugier, J-P</creatorcontrib><creatorcontrib>Metge, M</creatorcontrib><creatorcontrib>Hirsch, J-L</creatorcontrib><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><title>Annales de cardiologie et d'angeiologie</title><addtitle>Ann Cardiol Angeiol (Paris)</addtitle><description>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA<5), in three cases intense (EVA>5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures.
regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</description><subject>Aged</subject><subject>Analgesics, Non-Narcotic - administration & dosage</subject><subject>Analgesics, Opioid - administration & dosage</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - methods</subject><subject>Denervation - methods</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - surgery</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Morphine - administration & dosage</subject><subject>Nitrous Oxide - administration & dosage</subject><subject>Oxygen Compounds - administration & dosage</subject><subject>Pain - etiology</subject><subject>Pain - prevention & control</subject><subject>Pain Measurement</subject><subject>Renal Artery - surgery</subject><issn>0003-3928</issn><issn>1768-3181</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90FFLwzAQB_Agihtz30Akrz60Xpo2TXwbQ50w2ZC9j-uSrpEuKWk33Sfwa9sx9eng7nfH8SfklkHMgImHjxjdBoOOE2A8BhlDAhdkyHIhI84kuyRDAOARV4kckHHb2gKYEkmeM3FNBkkKAlKRDsn3u3FYU22cCQfsrHe09IEG09q2Q9fR6tiY0BnXnkaftqv8vqPbE-_X0Jm2q3qLjxT1ofe4NdSXFOnb02I5oTsfmso6Q5vgO7_xdUyXwdR2Zx2GIzVf_XFr3MbckKsS69aMf-uIrJ6fVtNZNF-8vE4n86hSkEbSlDlmKVOYZmKTZyLVkmkOSkMqlSoFJoViQnOWZRy1klrmBYBCQK4LKfiI3J_PVlivm2B3_Rdrj3Y9m8zXp14fJ-cykwfW27uzbfbFzuh__hce_wGVenWF</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Pansieri, M</creator><creator>Barnay, P</creator><creator>Larderet, E</creator><creator>Krebs, G</creator><creator>Aboukhoudir, F</creator><creator>Andrieu, S</creator><creator>Cheggour, S</creator><creator>Faugier, J-P</creator><creator>Metge, M</creator><creator>Hirsch, J-L</creator><general>Elsevier Masson</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-1142-770X</orcidid></search><sort><creationdate>201311</creationdate><title>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</title><author>Pansieri, M ; Barnay, P ; Larderet, E ; Krebs, G ; Aboukhoudir, F ; Andrieu, S ; Cheggour, S ; Faugier, J-P ; Metge, M ; Hirsch, J-L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h904-8ef7a5419a456c7564d81d309d04899f6a2b916d31553ad98d87b009a0a3db863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Analgesics, Non-Narcotic - administration & dosage</topic><topic>Analgesics, Opioid - administration & dosage</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - methods</topic><topic>Denervation - methods</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - surgery</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Morphine - administration & dosage</topic><topic>Nitrous Oxide - administration & dosage</topic><topic>Oxygen Compounds - administration & dosage</topic><topic>Pain - etiology</topic><topic>Pain - prevention & control</topic><topic>Pain Measurement</topic><topic>Renal Artery - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pansieri, M</creatorcontrib><creatorcontrib>Barnay, P</creatorcontrib><creatorcontrib>Larderet, E</creatorcontrib><creatorcontrib>Krebs, G</creatorcontrib><creatorcontrib>Aboukhoudir, F</creatorcontrib><creatorcontrib>Andrieu, S</creatorcontrib><creatorcontrib>Cheggour, S</creatorcontrib><creatorcontrib>Faugier, J-P</creatorcontrib><creatorcontrib>Metge, M</creatorcontrib><creatorcontrib>Hirsch, J-L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Annales de cardiologie et d'angeiologie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pansieri, M</au><au>Barnay, P</au><au>Larderet, E</au><au>Krebs, G</au><au>Aboukhoudir, F</au><au>Andrieu, S</au><au>Cheggour, S</au><au>Faugier, J-P</au><au>Metge, M</au><au>Hirsch, J-L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience</atitle><jtitle>Annales de cardiologie et d'angeiologie</jtitle><addtitle>Ann Cardiol Angeiol (Paris)</addtitle><date>2013-11</date><risdate>2013</risdate><volume>62</volume><issue>5</issue><spage>283</spage><pages>283-</pages><issn>0003-3928</issn><eissn>1768-3181</eissn><abstract>Renal denervation using the technique of radiofrequency is used only recently for the treatment of resistant hypertension. Normally, it is done under general anesthesia because the ablation point technique is painful. We suggest an alternative to general anesthesia comprising an association of morphin 0.1mg/kg IV to MEOPA (gas combining oxygen and azot protoxyd) delivered through an oxygen mask. Our series includes 12 consecutive patients treated between October 2011 and June 2013, the first five patients (group 1) have received only an hydroxizin and morphin sedation. Every five have felt the ablation painful, in two cases bearable pain (EVA<5), in three cases intense (EVA>5) pain leading to increasing doses of morphin, (total dose of 0.25mg/kg in two cases, 0.17mg in one case). For the seven following patients, a protocol including hydroxyzin, morphin and MEOPA given through a mask has been set up. Only one patient has felt a mild pain (EVA 5) leading to an increasing dose of morphin (total dose 0.17mg/kg). None of the six other patients has felt any pain during the procedure. The average dose of morphin is 0.17mg/kg in group 1, 0.11mg/kg in group 2. This is a preliminary study; if confirmed, it will allow a lot of hospitals without on-site possibilities of general anesthesia, to realize such procedures.
regarding pain, the procedure of renal ablation was well tolerated for six among seven patients receiving the association MEOPA and IV morphin. In contrast, in the five patients treated only with IV morphin, we observed a less good tolerance to pain and the need to increase the doses of IV morphin.</abstract><cop>France</cop><pub>Elsevier Masson</pub><pmid>24060464</pmid><doi>10.1016/j.ancard.2013.08.020</doi><orcidid>https://orcid.org/0000-0002-1142-770X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-3928 |
ispartof | Annales de cardiologie et d'angeiologie, 2013-11, Vol.62 (5), p.283 |
issn | 0003-3928 1768-3181 |
language | eng ; fre |
recordid | cdi_hal_primary_oai_HAL_hal_01333858v1 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | Aged Analgesics, Non-Narcotic - administration & dosage Analgesics, Opioid - administration & dosage Catheter Ablation - adverse effects Catheter Ablation - methods Denervation - methods Drug Combinations Female Humans Hypertension - surgery Life Sciences Male Middle Aged Morphine - administration & dosage Nitrous Oxide - administration & dosage Oxygen Compounds - administration & dosage Pain - etiology Pain - prevention & control Pain Measurement Renal Artery - surgery |
title | Renal denervation for resistant hypertension without general anesthesia: advantage of a MEOPA morphine protocol. Preliminary experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T03%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Renal%20denervation%20for%20resistant%20hypertension%20without%20general%20anesthesia:%20advantage%20of%20a%20MEOPA%20morphine%20protocol.%20Preliminary%20experience&rft.jtitle=Annales%20de%20cardiologie%20et%20d'angeiologie&rft.au=Pansieri,%20M&rft.date=2013-11&rft.volume=62&rft.issue=5&rft.spage=283&rft.pages=283-&rft.issn=0003-3928&rft.eissn=1768-3181&rft_id=info:doi/10.1016/j.ancard.2013.08.020&rft_dat=%3Chal_pubme%3Eoai_HAL_hal_01333858v1%3C/hal_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/24060464&rfr_iscdi=true |